Roots Analysis

• Flow Cytometry Services Market, 2022-2035

  Feb 15, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Flow Cytometry Services Market, 2022-2035 First introduced in 1950s, the flow cytometry technique has gained significant attention in the past few decades. This can be attributed to the fact that flow cytometry has been demonstrated to be capable of overcoming various challenges associated with conv ... Read More

• Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035

  Feb 09, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis ... Read More

• Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs): Analysis of Clinical Trial Results (Featuring Insightful Summaries of Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)

  Feb 02, 2022  |  Published by: Roots Analysis  |  USD 1,299

  Immune Checkpoint Inhibitors (PD-1 & PD-L1 Targeting Drugs): Analysis of Clinical Trial Results (Featuring Insightful Summaries of Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for No ... Read More

• Artificial Intelligence in Healthcare: Intellectual Property Landscape

  Jan 24, 2022  |  Published by: Roots Analysis  |  USD 1,299

  Artificial Intelligence in Healthcare: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis) The globa ... Read More

• Clinical Trials Software Market, 2022-2035: Distribution by Type of Deployment (on-cloud, on-premises), Type of Delivery (web-based, remote monitoring), Features of software (EDC, eCOA/ePRO, eConsent) and Geographical Regions (North America, Europe and Asia-Pacific)

  Jan 07, 2022  |  Published by: Roots Analysis  |  USD 4,799

  Clinical Trials Software Market, 2022-2035: Distribution by Type of Deployment (on-cloud, on-premises), Type of Delivery (web-based, remote monitoring), Features of software (EDC, eCOA/ePRO, eConsent) and Geographical Regions (North America, Europe and Asia-Pacific) 1. It is a well-known fact that c ... Read More

• Investor Series: Opportunities in the Telehealth Market (Focus on [A] Need for Telehealth Solutions / Services, [B] Landscape of Key Innovators, [C] Analysis of Product Offerings and Affiliated Value Propositions, [D] Insights from Historical Funding Activity, [E] Startup Health Indexing and Company Valuation Analysis, [F] Financial Analysis of Key Public Ventures, [G] Market Forecast and Opportunity Analysis, [H] Insights from Publicly Disclosed Investor Exits and [I] Key Acquisition Targets)

  Jan 04, 2022  |  Published by: Roots Analysis  |  USD 5,999

  Investor Series: Opportunities in the Telehealth Market (Focus on [A] Need for Telehealth Solutions / Services, [B] Landscape of Key Innovators, [C] Analysis of Product Offerings and Affiliated Value Propositions, [D] Insights from Historical Funding Activity, [E] Startup Health Indexing and Company ... Read More

< prev 7 8 9 10 11 12 next >